International Forum on Treatment of Schizophrenia (IFoTS)
Clinical Update on Advances in Treatment of Schizophrenia
20 APRIL 2013
JW MARRIOTT ORLANDO, GRANDE LAKES, FLORIDA, USA
Joint Sponsorship Statement
Jointly sponsored by Vanderbilt University School of Medicine Department of Psychiatry and INTERNATIONAL CONGRESS ON SCHIZOPHRENIA RESEARCH
After participating in this CME activity, participants should be able to:
- review the growing evidence that certain treatment targets are best addressed by alternative pharmacologic and nonpharmacologic approaches, including anti-inflammatory adjunctive therapies, med reduction approaches, and computer based cognitive rehabilitation approaches as first-line therapy for cognitive symptoms of schizophrenia.
- review optimal pharmacologic approaches to treatment-resistant schizophrenia and treatment nonadherence, using both didactic and case-based learning modules to reinforce practice-based learning
- review nonpharmacologic approaches to improve adherence assessment and improve medication adherence, as well as psychotherapeutic approaches to reducing distress and disability from treatment-resistant positive symptoms
This symposium will draw on the breadth and international scope of the ICOSR meeting to offer clinical practitioners breadth of faculty that would not usually be available at a single location.
Course Faculty with Institutional Affiliation and Credentials
Download (right click) or view (left click) a printable copy of the Clinical Update brochure
Agenda including Times, Topics, and Speakers
7.30a: Registration – Prefunction Area
9.00a: Improving Cognition in Schizophrenia: Current and Future Treatments – Phil Harvey
10.00a: Why do Medications Fail? Pharmacologic Approaches to Nonadherence and Medication-resistant
symptoms – Peter Haddad
11.00a: Break – Prefunction Area
11.15a: When Medications are Not Enough: Psychosocial Approaches to Nonadherence and Persistent Symptoms
Despite Optimal Psychopharmacology – Peter Weiden
12.00p: Lunch – Prefunction Area
1.00p: New Directions in Adjunctive Pharmacology of Schizophrenia: The Role of Inflammation in Disease Onset
and Progression – Diana Perkins
2:00p – 4.00p: Case Based Learning: Case Presentation with International Panel Treatment Discussion Reducing
Side Effect Burden – Peter Haddad and Peter Weiden
Assessment and Management of Adherence Problems
Assessment and Management of Treatment-resistance
Accreditation and Credit Designation Statements
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vanderbilt University School of Medicine and INTERNATIONAL CONGRESS ON SCHIZOPHRENIA RESEARCH. Vanderbilt University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Vanderbilt University School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Cancellation and Refund Statements
No refunds will be made for this activity. Vanderbilt University is not responsible for non-transferable, non-refundable airline tickets or hotel accommodations purchased in connection with attendance at this CME activity.
General – $80.00
Student – No fee; Must provide a signed letter from supervisor on institution letterhead verifying full-time student status to ICOSR@experient-inc.com or present onsite.
You may register and elect to receive CME credits in advance:
by creating a new account or adding it in to your current Registration
Create or log in to your account by clicking the Register button below
or contact Experient, Inc. at email@example.com
(001) 301.694.5243 or TOLL FREE 866-229-3691
Monday – Friday; 8:30am – 5:00pm EST